期刊文献+

CD_3AK/脂质体IL-2对肺癌患者的临床疗效 被引量:3

Clinical Effect of CD 3AK/IL 2 on Lung Cancer
下载PDF
导出
摘要 为了观察CD3AK/脂质体IL2对肺癌的疗效,应用CD3AK/脂质体IL2治疗20例肺癌患者,治疗后患者症状明显改善。血清生化指标,如唾液酸、癌胚抗原含量明显下降,胸片显示半数以上患者的肿块影缩小。可以认为CD3AK/脂质体IL2对肺癌患者有明显的治疗作用。 In order to approach the effect of anti CD 3 antibody induced activated killer cell(CD 3AK) and interleukin 2(IL 2) enveloped by liposomes on lung cancer,20 cases of lung cancer were treated with CD 3AK/IL 2.The results showed that after treatment,the symptoms were improve,the level of serum carcinoembryonic antigen and serum sialic acid significantly droped( P <0.01),and the tumor shade of x ray film was reduced.It indicates that CD 3AK/IL 2 treatment is remarkably effective for lung cancer.
机构地区 广东药学院内科
出处 《实用癌症杂志》 1998年第4期296-297,共2页 The Practical Journal of Cancer
关键词 肺癌 免疫疗法 CD3AK 脂质体 IL-2 Lung cancer Immunotherapy Effectiveness
  • 相关文献

同被引文献24

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部